NCT04869735

Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 2,125 (estimated)
• Sponsor: Université de Reims Champagne-Ardenne · Academic / Other
• Sex: All
• Age: 25 Years – 25 Years
• Healthy volunteers: Accepted

Summary

The aim of vaccination is to protect the patient against disease by stimulating his immune system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria, tetanus and polio. In France, the vaccination schedule sets the vaccination recommendations applicable to people according to their age. In this schedule, a booster of DTPolio at the age of 25 is recommended. The vaccination coverage for patients over 16 years of age is insufficient in France.

Detailed description

The aim of the study is to evaluate impact of information about booster vaccination against DTPolio at 25 years on this booster vaccination's realization.

Conditions

• Vaccination

Interventions

Type	Name	Description
OTHER	Data collection: DTPolio vaccine delivery	"with information about booster vaccination" group: Sending of information concerning booster vaccination against DTPolio at 25 years using letters, emails and SMS "without information about booster vaccination" group: no intervention

Timeline

• Start date: 2021-06-04
• Primary completion: 2022-06-01
• Completion: 2022-09-01
• First posted: 2021-05-03
• Last updated: 2021-07-06

Locations

1 site across 1 country: France